Executive Summary
Core view: Q1 revenue and EBITDA grew 25.9% and 30.7%, respectively, but a roughly 9-10% tax rate materially supported PAT while PBT declined. Global qualifications and capacity expansion offer a long runway; negative CFO, debt and extreme valuation demand disciplined execution.
Azad manufactures mission-critical turbine, airfoil, aerospace and oil-and-gas components for global OEMs. Long approvals, dedicated lines and difficult tolerances create a moat; multi-year supply agreements provide demand visibility but not a conventional disclosed order-book number.
Q1 FY27 Snapshot
Revenue₹172.60 Cr+25.9% YoY
EBITDA₹64.36 Cr+30.7% YoY
EBITDA margin37.3%vs about 36.0%
PAT₹35.16 Cr+19.5% YoY
PBT declined to about ₹39 crore, while tax fell to roughly ₹3.7 crore. Q1 PAT therefore benefited materially from an approximately 9-10% effective tax rate that should not be assumed recurring.
Business Position
Strengths
- Qualified supplier to global energy and aerospace OEMs.
- High-value components with demanding tolerances.
- Q1 EBITDA margin of 37.3%.
- Exports represented 88% of Q1 standalone revenue.
Constraints
- No single conventional order-book value is disclosed.
- FY26 CFO was negative ₹119 crore.
- Borrowings were ₹474 crore before the full capex ramp.
- Customer qualifications can take 30-48 months.
Growth Drivers And Capacity Economics
| Driver | Evidence | Investment test |
|---|---|---|
| Phase-1 expansion | About 94,899 sqm under construction; four dedicated facilities inaugurated | H2 FY27 contribution should improve asset turns and cash generation. |
| Centre of Excellence | Civil completion targeted in FY27 | Advanced turbine and airfoil work must ramp after qualification. |
| Aerospace | 16.8% of Q1 standalone revenue | New contracts should diversify an energy-heavy mix. |
| International expansion | Saudi capacity initiative | Customer proximity must justify added capital and execution complexity. |
Azad has 20,000 sqm operational and substantial Phase-1 and Phase-2 expansion planned. Multi-year supply agreements support visibility, but should not be presented as a conventional firm order book.
Management Guardrails And Credibility
| Operating objective | Status | Evidence required |
|---|---|---|
| Long-term revenue growth above 25% | On track in Q1 | Growth must persist at normalized tax and cash conversion. |
| Larger H2 FY27 facility contribution | In progress | Commissioned lines should lift utilization and customer shipments. |
| Expand aerospace mix | Developing | Qualified contracts need to enter serial production. |
| Fund expansion responsibly | Watch | CFO must improve against ₹474 crore borrowings. |
Management's growth ambition is supported by contracted relationships and dedicated capacity. The credibility test is not only revenue: free cash flow and return on newly deployed capital must improve.
Financial Quality
FY26 revenue₹603 Cr+32% YoY
FY26 PAT₹134 Cr+54% YoY
FY26 borrowings₹474 CrCapex funding load
FY26 CFO-₹119 CrWeak conversion
| Quality test | Reading | Interpretation |
|---|---|---|
| ROCE | 11.9% | Low relative to reported margin and valuation. |
| Cash conversion | Negative ₹119 crore CFO | Growth absorbed cash through working capital and expansion. |
| Tax quality | Q1 effective rate about 9-10% | PAT growth overstates underlying PBT performance. |
| Export exposure | 88% in Q1; 93% in FY26 | Global reach is a strength with currency and concentration risk. |
Valuation
At ₹2,849.10 on 11 September 2026, market capitalization was approximately ₹18,400 crore and trailing P/E about 132.4x. The valuation assumes many years of high growth and successful capacity monetization.
| Scenario | FY28 revenue | PAT margin | Illustrative PAT | Current market-cap / PAT |
|---|---|---|---|---|
| Bear | ₹800 Cr | 17% | ₹136 Cr | 135x |
| Base | ₹900 Cr | 20% | ₹180 Cr | 102x |
| Bull | ₹1,025 Cr | 23% | ₹236 Cr | 78x |
The current multiple remains high even under aggressive execution. The investment case requires both compounding and a substantial improvement in cash conversion and return on capital.
Key Risks
- Negative operating cash flow persists through the capex ramp.
- Customer or programme concentration affects utilization.
- Qualifications and new-facility approvals take longer than expected.
- Export currency and geopolitical exposure.
- Q1's low tax rate proves non-recurring.
Annual Projection
| Period | Revenue | EBITDA margin | PAT | Key condition |
|---|---|---|---|---|
| FY27E | ₹753-783 Cr | 38-39% | ₹133-146 Cr | H2 capacity ramps and tax normalizes. |
| FY28E | ₹850-975 Cr | 38-40% | ₹165-215 Cr | Dedicated lines reach serial production. |
| FY29E | ₹1,050-1,225 Cr | 39-41% | ₹220-285 Cr | Airfoil, engine and international capacity scales. |
These are analytical scenarios based on management's long-term growth objective, not a disclosed conventional order book. EPS uses approximately 6.46 crore shares and assumes a normalized tax rate.
Investor Watchlist
- Effective tax rate and PBT growth.
- Operating cash flow, receivables and inventory.
- Phase-1 commissioning and H2 contribution.
- Aerospace versus energy revenue mix.
- Debt, capex and return on capital.
Sources Used
Prepared on 13 September 2026 from public information. Forecasts are analytical estimates and not investment advice.